After Voce Capital Management sent a letter to Air Methods (AIRM) stating that the company has received "highly credible inbound" interest from private equity firms, William Blair analyst Ryan Daniels says going private interest in the name is "logical." Applying a 9.5-times multiple to his 2015 EBITDA forecast, the multiple reportedly paid by KKR recently for Air Medical Group Holdings, Air Methods would be worth $51.50 per share, Daniels tells investors in a research note. The analyst believes a $54 price target is reasonable for the company under a leveraged buyout scenario. He views the stock's risk/reward as favorable and keeps an Outperform rating on the name.